Overview

An Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
This is an observational, prospective, non-interventional, non-randomised, open label multicentric study planned to be conducted in 1000 subjects with mild to moderate primary hypertension in approximately 20 centres in Thailand. The purpose of this study is to examine the beneficial effects of combination of bisoprolol with hydrochlorothiazide available as Lodoz in treatment of Thai subjects with mild to moderate hypertension. The outcome of the study would also provide information on the optimal daily dosage schedule as well as adherence of Lodoz.
Details
Lead Sponsor:
Merck KGaA
Merck KGaA, Darmstadt, Germany
Treatments:
Bisoprolol
Hydrochlorothiazide